These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
447 related articles for article (PubMed ID: 32932782)
1. Milk Exosomes: Perspective Agents for Anticancer Drug Delivery. Sedykh S; Kuleshova A; Nevinsky G Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932782 [TBL] [Abstract][Full Text] [Related]
2. Milk Exosomes: Next-Generation Agents for Delivery of Anticancer Drugs and Therapeutic Nucleic Acids. Timofeeva AM; Paramonik AP; Sedykh SS; Nevinsky GA Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373342 [TBL] [Abstract][Full Text] [Related]
3. Exosome-like Nanovectors for Drug Delivery in Cancer. Arrighetti N; Corbo C; Evangelopoulos M; Pastò A; Zuco V; Tasciotti E Curr Med Chem; 2019; 26(33):6132-6148. PubMed ID: 30182846 [TBL] [Abstract][Full Text] [Related]
4. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics. Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978 [TBL] [Abstract][Full Text] [Related]
5. Exosomes as Targeted Delivery Drug System: Advances in Exosome Loading, Surface Functionalization and Potential for Clinical Application. Guo ZY; Tang Y; Cheng YC Curr Drug Deliv; 2024; 21(4):473-487. PubMed ID: 35702803 [TBL] [Abstract][Full Text] [Related]
6. Exosomes: Isolation, Analysis, and Applications in Cancer Detection and Therapy. Bu H; He D; He X; Wang K Chembiochem; 2019 Feb; 20(4):451-461. PubMed ID: 30371016 [TBL] [Abstract][Full Text] [Related]
7. The Potential of Milk-Derived Exosomes for Drug Delivery. Li S; Tang Y; Dou Y Curr Drug Deliv; 2021; 18(6):688-699. PubMed ID: 32807052 [TBL] [Abstract][Full Text] [Related]
8. Plant exosome nanovesicles (PENs): green delivery platforms. Cao M; Diao N; Cai X; Chen X; Xiao Y; Guo C; Chen D; Zhang X Mater Horiz; 2023 Oct; 10(10):3879-3894. PubMed ID: 37671650 [TBL] [Abstract][Full Text] [Related]
9. Organically derived exosomes as carriers of anticancer drugs and imaging agents for cancer treatment. Srivastava A; Rathore S; Munshi A; Ramesh R Semin Cancer Biol; 2022 Nov; 86(Pt 1):80-100. PubMed ID: 35192929 [TBL] [Abstract][Full Text] [Related]
11. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Kim MS; Haney MJ; Zhao Y; Mahajan V; Deygen I; Klyachko NL; Inskoe E; Piroyan A; Sokolsky M; Okolie O; Hingtgen SD; Kabanov AV; Batrakova EV Nanomedicine; 2016 Apr; 12(3):655-664. PubMed ID: 26586551 [TBL] [Abstract][Full Text] [Related]
12. Enhanced exosome-mediated delivery of black bean phytochemicals (Phaseolus vulgaris L.) for cancer treatment applications. Donoso-Quezada J; Guajardo-Flores D; González-Valdez J Biomed Pharmacother; 2020 Nov; 131():110771. PubMed ID: 33152932 [TBL] [Abstract][Full Text] [Related]
13. Construction and Evaluation of Liraglutide Delivery System based on Milk Exosomes: A New Idea for Oral Peptide Delivery. Shi Y; Guo S; Liang Y; Liu L; Wang A; Sun K; Li Y Curr Pharm Biotechnol; 2022; 23(8):1072-1079. PubMed ID: 34414872 [TBL] [Abstract][Full Text] [Related]
14. Exosomes as Theranostics for Lung Cancer. Srivastava A; Amreddy N; Razaq M; Towner R; Zhao YD; Ahmed RA; Munshi A; Ramesh R Adv Cancer Res; 2018; 139():1-33. PubMed ID: 29941101 [TBL] [Abstract][Full Text] [Related]
15. A Natural Membrane Vesicle Exosome-based Sinomenine Delivery Platform for Hepatic Carcinoma Therapy. Wang Y; Zhao L; Yuan W; Liang L; Li M; Yu X; Wang Y Curr Top Med Chem; 2021 Oct; 21(14):1224-1234. PubMed ID: 34126903 [TBL] [Abstract][Full Text] [Related]
16. Bovine milk-derived exosomes for drug delivery. Munagala R; Aqil F; Jeyabalan J; Gupta RC Cancer Lett; 2016 Feb; 371(1):48-61. PubMed ID: 26604130 [TBL] [Abstract][Full Text] [Related]
17. Potential therapeutic effects of milk-derived exosomes on intestinal diseases. Cui Z; Amevor FK; Zhao X; Mou C; Pang J; Peng X; Liu A; Lan X; Liu L J Nanobiotechnology; 2023 Dec; 21(1):496. PubMed ID: 38115131 [TBL] [Abstract][Full Text] [Related]
18. Milk exosomes: A biogenic nanocarrier for small molecules and macromolecules to combat cancer. Kandimalla R; Aqil F; Tyagi N; Gupta R Am J Reprod Immunol; 2021 Feb; 85(2):e13349. PubMed ID: 32966664 [TBL] [Abstract][Full Text] [Related]
19. Engineering exosomes as refined biological nanoplatforms for drug delivery. Luan X; Sansanaphongpricha K; Myers I; Chen H; Yuan H; Sun D Acta Pharmacol Sin; 2017 Jun; 38(6):754-763. PubMed ID: 28392567 [TBL] [Abstract][Full Text] [Related]
20. Functionalized exosome harboring bioactive molecules for cancer therapy. Kim YK; Choi Y; Nam GH; Kim IS Cancer Lett; 2020 Oct; 489():155-162. PubMed ID: 32623071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]